SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-121801
Filing Date
2020-04-28
Accepted
2020-04-28 06:14:26
Documents
5
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d860861ddefa14a.htm DEFA14A 19558
2 GRAPHIC g860861d860861d1.jpg GRAPHIC 100182
3 GRAPHIC g860861d860861d2.jpg GRAPHIC 139617
4 GRAPHIC g860861d860861d3.jpg GRAPHIC 71750
5 GRAPHIC g860861d860861d4.jpg GRAPHIC 19283
  Complete submission text file 0001193125-20-121801.txt   455104
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36517 | Film No.: 20822163
SIC: 2834 Pharmaceutical Preparations